FDA Virtual Town Hall Series

The FDA is continuing their weekly virtual town hall series presenting guidance on COVID-19 diagnostic testing. 

On April 15, 2020, from 12:15 pm – 1:15 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SARS-CoV-2. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2.

The FDA also plans to hold virtual Town Halls for clinical laboratories and commercial manufacturers to help answer questions on the following dates:

  • April 22, 2020 from 12:15 pm – 1:15 pm Eastern Time
  • April 29, 2020 from 12:15 pm – 1:15 pm Eastern Time

Visit https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/virtual-town-hall-series-immediately-effect-guidance-coronavirus-covid-19-diagnostic-tests-04152020 for call-in information and access to previously recorded sessions.

BIOCENTURY: Updates on Therapeutic Advances

In response to the urgent need for information about the coronavirus crisis, BioCentury is providing a free information portal containing resources for the biopharma industry, and coverage on policy developments, scientific advances, and progress on countermeasures for COVID-19.



Directory of COVID Diagnostic Pipeline

Active overview of all SARS-CoV-2 tests commercially available or in development for the diagnosis of COVID-19. Collated by test suppliers or obtained from publicly available sources.



COVID Webinars: Accelerating Therapeutics for COVID-19

Join the webinar to hear from collaborators in the COVID-19 Therapeutics Accelerator.

Topics Including:

  • Lessons we can apply from past viral pandemics
  • How smarter drug development accelerates therapeutics
  • Activities and learnings to date at the COVID-19 Therapeutics Accelerator
  • Tools, protocols, and resources for research studies in development
Dr. Dan Hartman, Director of Integrated Development, Bill & Melinda Gates Foundation
Dr. Steven Kern, Deputy Director of Quantitative Sciences, Bill & Melinda Gates Foundation
Dr. Craig Rayner, President of Integrated Drug Development, Certara
Dr. Fran Brown, SVP of Integrated Drug Development, Certara
Date: April 8, 2020
Time: 1:00 pm ET
Duration: 1 hour


FDA Policy on COVID-19 Testing During Public Health Emergency

On March 25, 2020, the FDA held a virtual town hall to present their policy regarding running newly developed & validated SARS-CoV-2 tests prior to Emergency Use Authorization. The presentation is now available for download at https://www.fda.gov/media/136439/download.

Here is their summary slide:


Attend SDEE Events Donate | Sponsor SDEE Become a Member

Connect with SDEE

Sign Up for SDEE Newsletter


Morrison Foerster Alexandria


Ted Jacobs
Vice Chairman
Global Life Sciences Practices Group


Takeda San Diego BDO logo


MaxCyte Barney and Barney Longfellow Pineapple.gif

SDEE is a nonprofit 501(c)(3) organization founded by local San Diego entrepreneurs
in order to provide a voice for the early stage start-up, to support new entrepreneurs and their companies,
and to sponsor networking and educational events
to help develop the skills necessary to bring funding, business, and jobs to the San Diego area.

© 2015 San Diego Entrepreneurs Exchange. All Rights Reserved